Envafolimab plus chemotherapy in advanced gastric or gastroesophageal junction (G/GEJ) cancer.Xianli Yin, Dongfang Liu, Jianming Xu et al.|Journal of Clinical Oncology|2020Cited by 6
Health-related quality-of-life results from SANET-ep: A phase III study of surufatinib versus placebo for advanced extrapancreatic neuroendocrine tumors.Chunmei Bai, Weiguo Su, Jianming Xu et al.|Journal of Clinical Oncology|2020Cited by 1